Skip navigation
Speakers

Evaluate the Impact of Potential Changes for Pharmacies and PBMs

June 13-14, 2019
  • Washington, DC

Daniel Ashworth
Counsel for Ranking Member Doug Collins and
the House Judiciary Committee Minority
U.S. House of Representatives

Dea Belazi, Pharm.D.,MPH
President & CEO
AscellaHealth LLC

Matthew Chamblee, FSA, MAAA
Principal and Consulting Actuary
Milliman, Inc.

Laura Cranston
Chief Executive Officer
Pharmacy Quality Alliance (PQA)

Sean Dickson, JD, MPH
Officer, Drug Spending Research Initiative
The Pew Charitable Trusts

David Farber
Partner, FDA and Life Sciences
King & Spalding

Kyle Fields
Chief Executive Officer
Appro-RX

Matthew Hayes FSA, MAAA
Consulting Actuary
Milliman, Inc.

John M. O’Brien, PharmD
Senior Advisor to the Secretary for Drug Pricing Reform
U.S. Department of Health and Human Services (invited)

Sherry Pound
Principal
BluePeak Advisors

Todd Sega, PharmD
Vice President, Payer Relations
Pharmacy Quality Solutions (PQS)

Kala Shankle, JD
Director, Policy & Regulatory Affairs
National Community Pharmacists Association

Gordon Smith
Director, Pharmacy Revenue Cycle
Vanderbilt University Medical Center

Michelle Templin
Vice President, Strategic Business Development
Managed Health Care Associates, Inc.

Paul Urick, RPh
Chief Executive Officer
URx

Daniel Ashworth
Counsel for Ranking Member Doug Collins and
the House Judiciary Committee Minority
U.S. House of Representatives

Dea Belazi, Pharm.D.,MPH
President & CEO
AscellaHealth LLC

Matthew Chamblee, FSA, MAAA
Principal and Consulting Actuary
Milliman, Inc.

Laura Cranston
Chief Executive Officer
Pharmacy Quality Alliance (PQA)

Sean Dickson, JD, MPH
Officer, Drug Spending Research Initiative
The Pew Charitable Trusts

David Farber
Partner, FDA and Life Sciences
King & Spalding

Kyle Fields
Chief Executive Officer
Appro-RX

Matthew Hayes FSA, MAAA
Consulting Actuary
Milliman, Inc.

John M. O’Brien, PharmD
Senior Advisor to the Secretary for Drug Pricing Reform
U.S. Department of Health and Human Services (invited)

Sherry Pound
Principal
BluePeak Advisors

Todd Sega, PharmD
Vice President, Payer Relations
Pharmacy Quality Solutions (PQS)

Kala Shankle, JD
Director, Policy & Regulatory Affairs
National Community Pharmacists Association

Gordon Smith
Director, Pharmacy Revenue Cycle
Vanderbilt University Medical Center

Michelle Templin
Vice President, Strategic Business Development
Managed Health Care Associates, Inc.

Paul Urick, RPh
Chief Executive Officer
URx